Human GLP-1 receptor transmembrane domain structure in complex with allosteric modulators
The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Abstract
The glucagon-like peptide-1 receptor (GLP-1R) and the glucagon receptor (GCGR) are members of the secretin-like class B family of G-protein-coupled receptors (GPCRs) and have opposing physiological roles in insulin release and glucose homeostasis. The treatment of type 2 diabetes requires positive modulation of GLP-1R to inhibit glucagon secretion and stimulate insulin secretion in a glucose-dependent manner. Here we report crystal structures of the human GLP-1R transmembrane domain in complex with two different negative allosteric modulators, PF-06372222 and NNC0640, at 2.7 and 3.0 Å resolution, respectively. The structures reveal a common binding pocket for negative allosteric modulators, present in both GLP-1R and GCGR and located outside helices V-VII near the intracellular half of the receptor. The receptor is in an inactive conformation with compounds that restrict movement of the intracellular tip of helix VI, a movement that is generally associated with activation mechanisms in class A GPCRs. Molecular modelling and mutagenesis studies indicate that agonist positive allosteric modulators target the same general region, but in a distinct sub-pocket at the interface between helices V and VI, which may facilitate the formation of an intracellular binding site that enhances G-protein coupling.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In this same study, enhanced compound 2 potency was demonstrated by GLP-1R when its residue 332 was mutated to tryptophan, which is in contrast to the effect observed with this mutation on the potency of allosteric antagonists. It was postulated that enhanced compound 2 potency was caused by increased hydrophobic interactions between the receptor and the agonist with this mutation.”
From A review of current trends with type 2 diabetes epidemiology, aetiology, pathogenesis, treatments and future perspectives (2021) · cites this paper as [288]
In the citing paper
“Residues 328, 351 and 335 of GLP-1R were recently demonstrated to be important for compound 2 potency, as mutagenesis of these residues reduced compound 2 activity.288”
From A review of current trends with type 2 diabetes epidemiology, aetiology, pathogenesis, treatments and future perspectives (2021) · cites this paper as [288]
Citations
Cites
Molecular dynamics with coupling to an external bath
Berendsen, H. J. C., Postma, J. P. M., van Gunsteren, W. F., DiNola, A., & Haak, J. R. (1984) · The Journal of Chemical Physics · doi:10.1063/1.448118 · Cited by 30,700
Features and development of Coot
Emsley, P., Lohkamp, B., Scott, W. G., & Cowtan, K. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444910007493 · Cited by 29,915
PHENIX : a comprehensive Python-based system for macromolecular structure solution
Adams, P. D., Afonine, P. V., Bunkóczi, G., Chen, V. B., Davis, I. W., Echols, N., Headd, J. J., Hung, L.-W., Kapral, G. J., Grosse-Kunstleve, R. W., et al. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444909052925 · Cited by 23,716
Phaser crystallographic software
McCoy, A. J., Grosse-Kunstleve, R. W., Adams, P. D., Winn, M. D., Storoni, L. C., & Read, R. J. (2007) · Journal of Applied Crystallography · doi:10.1107/s0021889807021206 · Cited by 20,612
Canonical sampling through velocity rescaling
Bussi, G., Donadio, D., & Parrinello, M. (2007) · The Journal of Chemical Physics · doi:10.1063/1.2408420 · Cited by 18,089
Kabsch, W. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444909047337 · Cited by 16,463
MolProbity : all-atom structure validation for macromolecular crystallography
Chen, V. B., Arendall, W. B., Headd, J. J., Keedy, D. A., Immormino, R. M., Kapral, G. J., Murray, L. W., Richardson, J. S., & Richardson, D. C. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444909042073 · Cited by 14,115
GROMACS 4.5: a high-throughput and highly parallel open source molecular simulation toolkit
Pronk, S., Páll, S., Schulz, R., Larsson, P., Bjelkmar, P., Apostolov, R., Shirts, M. R., Smith, J. C., Kasson, P. M., van der Spoel, D., et al. (2013) · Bioinformatics · doi:10.1093/bioinformatics/btt055 · Cited by 7,473
PHENIX: a comprehensive Python-based system for macromolecular structure solution
Adams, P. D., Afonine, P. V., Bunkóczi, G., Chen, V. B., Davis, I. W., Echols, N., Headd, J. J., Hung, L.-W., Kapral, G. J., Grosse-Kunstleve, R. W., et al. (2012) · International Tables for Crystallography · doi:10.1107/97809553602060000865 · Cited by 7,334
Madhavi Sastry, G., Adzhigirey, M., Day, T., Annabhimoju, R., & Sherman, W. (2013) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-013-9644-8 · Cited by 6,006
Cited by
Items 201–250 of 250
Ghosh, K., & Sobhia, M. E. (2022) · Research Square · doi:10.21203/rs.3.rs-1721735/v1 · Cited by 2
Activation of Class B GPCR by Peptide Ligands: General Structural Aspects
Ernicke, S., & Coin, I. (2022) · Wiley eBooks · doi:10.1002/9781119564782.ch10 · Cited by 1
Zhao, W., Yin, Y., Shi, Z., Yang, K., Li, X., Yang, Y., Jing, T., & Kang, Z. (2025) · Molecular Diversity · doi:10.1007/s11030-025-11213-7 · Cited by 1
Poudel, H., Shaon, P. H., Wales, D. J., & Leitner, D. M. (2025) · Physical Chemistry Chemical Physics · doi:10.1039/d5cp02918j · Cited by 2
Kour, S., Pradhan, S. K., Rath, P. K., Mishra, B. P., Jena, M. K., Paital, B., Singh, S., & Sahoo, D. K. (2025) · Computational and Structural Biotechnology Reports · doi:10.1016/j.csbr.2025.100069 · Cited by 1
Chen, Y., Li, J., Delemotte, L., & Mu, Y. (2026) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.6c00224 · Cited by 1
Caspi, A., Khazanov, N., Helman, A., Lankry, H., Levavi‐Sivan, B., Senderowitz, H., & Kerem, Z. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27125630 · Cited by 1
Thamaraiselvan, V., & Ravichandiran, V. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1835720 · Cited by 1
In silico prediction of GLP-1R agonists using machine learning approach
Kuang, Z., Cheng, X., Yang, Z., Guo, Y.-X., Huang, Y., & Su, Z. (2021) · Chemical Papers · doi:10.1007/s11696-021-01600-3 · Cited by 2
ADA: An Application-Conscious Data Acquirer for Visual Molecular Dynamics
Wu, H., Deng, T., Zou, Y., Yin, S., Chen, S., & Xie, T. (2021) · Proceedings of the International Conference on Parallel Processing · doi:10.1145/3472456.3473509 · Cited by 1
Glucagon receptor family in GtoPdb v.2021.3
BATAILLE, D., Chan, S. L. F., Delagrange, P., Drucker, D. J., Göke, B., Hills, R., Mayo, K. E., Miller, L. J., Salvatori, R., & Thorens, B. (2021) · IUPHAR/BPS Guide to Pharmacology CITE · doi:10.2218/gtopdb/f29/2021.3 · Cited by 1
Hanson, M. A., & Orencia, M. C. (2022) · Wiley eBooks · doi:10.1002/9781119564782.ch9 · Cited by 1
Self-citationZhang, B., Zhao, S., Yang, D., Wu, Y., Xin, Y., Cao, H., Huang, X., Cai, X., Sun, W., Ye, N., et al. (2020) · ACS Central Science · doi:10.1021/acscentsci.0c00448 · Cited by 1
Self-citationTyp‐B‐GPCR‐Strukturen verdeutlichen Aktivierungsmechanismus
Hausch, F. (2017) · Angewandte Chemie · doi:10.1002/ange.201707200
Clinical and basic studies of GLP-1 receptor agonists for the treatment of diabetes in China
Hong, T., Liu, J., & Wei, R. (2018) · Scientia Sinica Vitae · doi:10.1360/n052018-00030 · Cited by 1
Sexton, P. M., & Furness, S. G. B. (2018) · F1000 - Post-publication peer review of the biomedical literature · doi:10.3410/f.733830033.793550552
Papers of note in Nature 546 (7657)
VanHook, A. M. (2017) · Science Signaling · doi:10.1126/scisignal.aao0451
Generation and use of new tools for the characterisation of gut hormone receptors
Biggs, E. K. (2018) · Apollo (University of Cambridge) · doi:10.17863/cam.37487
Glucagon receptor family (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database
BATAILLE, D., Chan, S. L. F., Delagrange, P., Drucker, D. J., Göke, B., Hills, R., Mayo, K. E., Miller, L. J., Salvatori, R., & Thorens, B. (2019) · IUPHAR/BPS Guide to Pharmacology CITE · doi:10.2218/gtopdb/f29/2019.4
Chikazawa, M., Moriwaki, Y., Uramoto, M., Yamauchi, Y., Shimizu, M., Shimizu, K., & Sato, R. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.03.189
Understanding and drugging the Bcl-2 transmembrane interactome for tumor treatment
Lucendo, E. (2020) · RiuNet (Universitat Politècnica de València) · doi:10.4995/thesis/10251/155914
Zhu, Z., Zhen, Z., Chen, H., Jin, Z., Chen, J., Gu, D., Luo, Q., Yan, X., & Yang, R. (2020) · doi:10.21203/rs.3.rs-74933/v1
Functional Study on the GLP-1 Based Drug Liraglutide in High Fat Diet Fed Mice
Khroud, M. (2020) · TSpace (University of Toronto)
Development and Application of Biochemical Characterization Methods for Protein Structure Analysis
広実, 慶., ヒロザネ, ヨ., & Hirozane, Y. (2021) · Terrestrial Environment Research Center (University of Tsukuba) · Cited by 1
Computer modeling of allosteric modulators at G protein-coupled receptors
Brandt, A. L. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-819771-4.00007-5
Bortolato, A., & Mason, J. S. (2022) · Wiley eBooks · doi:10.1002/9781119627784.ch9
Sexton, P. M. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.737509212.793574968
Computational and experimental approaches to probe GPCR activation and signaling
Dragan, P., Atzei, A., Sanmukh, S. G., & Latek, D. (2022) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2022.06.001 · Cited by 1
Zhou, B., Li, J., Fang, C., Huang, Y., Sang, G., Tao, S., & He, C. (2023) · PubMed Central · doi:10.12122/j.issn.1673-4254.2023.03.14
Signal Transduction-Related MPs: GPCR
Zhang, X. C. (2025) · Springer eBooks · doi:10.1007/978-981-96-1321-2_8
Discovery of Feeding Regulatory Peptides and The Importance of Peptide Discovery Research
Ida, T., Matsui, K., Nagata, S., Nakamachi, T., Shiimura, Y., Sato, T., & Kojima, M. (2024) · The Kurume Medical Journal · doi:10.2739/kurumemedj.ms7134001
Plascencia‐Villa, G., Xu, R., & Perry, G. L. (2025) · Annals of Internal Medicine · doi:10.7326/annals-25-02362
Özgen, N., & Çömez, A. (2025) · İletişim ve Diplomasi · doi:10.54722/iletisimvediplomasi.1666043
Towards the Structures of the Parathyroid Hormone Receptors
Henderson, J. G. (2021) · White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York) · Cited by 1
GLP-1 receptor and Mitochondria-ER Contact Sites: an emerging mechanism of metabolic regulation
Cruz, P., Puebla-Huerta, A., Troncoso, M. F., Silva-Pavez, E., Hidalgo, Y., & Ahumada-Castro, U. (2026) · Frontiers in Physiology · doi:10.3389/fphys.2026.1826699
Breaking Barriers: Latest Frontiers in GPCR Structural Analysis
Jawarkar, R. D., Ajmire, P. V., Wadekar, A., Dewani, A., & Mohale, D. (2026) · Springer eBooks · doi:10.1007/978-981-95-9081-0_5
Uncovering Allosteric Signaling Pathways of GLP-1R via Molecular Dynamics and Network TheoryPreprint
Tran, L., Li, Z., & Moore, P. (2026) · Research Square · doi:10.21203/rs.3.rs-10245055/v1
Dong, Z., Cheng, L., Shi, Q., Luo, Y., Ning, K., Ye, L., Tu, Y., & Shi, Z. (2026) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2026.153824
Self-citationMolecular design and delivery of extracellular and membrane protein degradation chimeras
Lin, S., Zhou, H., Qiu, J., Dang, Y., Kou, L., Zhu, Z., Xu, Z., Lai, Y., & Yu, H. (2026) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2026.115959
Hu, J., Zhang, Y., Wang, M., Zhang, B., Zhang, B., Ke, C., Tang, C., Xia, J., Zhao, Q., Gao, H., et al. (2026) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6c00175
Self-citationMartino, S. D., & Rosa, M. D. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1930768
Alharbi, N. H. J. (2026) · Pharmacology Research & Perspectives · doi:10.1002/prp2.70329
Landscape of Endocytic Effectors for Extracellular Targeted Protein Degradation
Liang, Y., Shao, S., Chen, Y., 司晶星, & Shen, Y. (2026) · Medicinal Research Reviews · doi:10.1002/med.70112
BindingDB (2025) · UC San Diego · doi:10.7270/q29z99hx
Prediction of the mechanisms of hepatotropic action of maloben using molecular docking
Sauts, A. V., Александровна, П. В., Titovich, I. A., & Okovityi, S. V. (2026) · Drug development & registration · doi:10.33380/2305-2066-2026-15-4-2370
Metadata
- Authors
- Song, G., Yang, D., Wang, Y., de Graaf, C., Zhou, Q., Jiang, S., Liu, K., Cai, X., Dai, A., Lin, G., Liu, D., Wu, F., Wu, Y., Zhao, S., Ye, L., Han, G. W., Lau, J., Wu, B., Hanson, M. A., Liu, Z.-J., Wang, M.-W., & Stevens, R. C.
- Affiliations
- ShanghaiTech University (CN)
- Chinese Academy of Sciences (CN)
- Fudan University (CN)
- University of Southern California (US)
- Novo Nordisk (Denmark) (DK)
- Kunming Medical University (CN)
- Corresponding author
- Liu, Zhi-Jie
- Wang, Ming-Wei
- Stevens, Raymond C.
- ORCID
- Venue
- Nature
- Published
- 2017-05-17
- Volume
- 546
- Issue
- 7657
- Pages
- 312-315
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2616258954
- Cited by
- 241
- References
- 50
- Citations by year
- 2026: 12 · 2025: 23 · 2024: 18 · 2023: 22 · 2022: 23 · 2021: 27 · 2020: 32 · 2019: 38 · 2018: 31 · 2017: 15
- FWCI
- 13.07
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- VU Research Portal (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Keywords
- GLP-1 receptor, transmembrane domain structure, negative allosteric modulators, receptor activation mechanism, class B GPCRs, glucagon receptor, G protein coupling, type 2 diabetes, peptide agonists, glucagon-like peptide-1
- MeSH terms
- Glucagon-Like Peptide-1 Receptor, Protein Domains, Glucagon-Like Peptide-1 Receptor Agonists, Allosteric Regulation, Allosteric Site, Amino Acid Sequence, Aminopyridines, Benzamides, Humans, Models, Molecular, Phenylurea Compounds, Crystallography, X-Ray
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.